102 related articles for article (PubMed ID: 1530674)
21. Cardiohemodynamic effect of a novel calcium antagonist, SD-3211, in the dog.
Takada T; Miyawaki N; Nishimura K; Nakata K; Matsuno K; Ishida N; Yamauchi H; Iso T
Arch Int Pharmacodyn Ther; 1991; 309():75-87. PubMed ID: 1888232
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
Satoh K; Kawada M; Wada Y; Taira N
Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
[TBL] [Abstract][Full Text] [Related]
23. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system.
Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
Takahashi K; Taira N
Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 1st communication: comparative studies on the cardiovascular effects of methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2,3- b]pyridine-5-carboxylate and its two enantiomers in experimental animals.
Ueda M; Matsumura S; Masui M; Matsuura E; Uno O; Kawakami M; Ninomiya M; Adachi I
Arzneimittelforschung; 1993 Dec; 43(12):1270-5. PubMed ID: 8141813
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular effects of the new dihydropyridine derivative elgodipine.
Tamargo J; López-Sendón J; Delpón E; González-Morales M; de Miguel E
Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916
[TBL] [Abstract][Full Text] [Related]
28. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
Tsuchida K; Yamazaki R; Kaneko K; Aihara H
Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular effects of the new calcium antagonist isradipine and of diltiazem in anesthetized open-chest dogs.
Sakanashi M; Miyamoto Y; Noguchi K; Kato T; Matsuzaki T; Miyagi H; Ikema S; Kinjo N
Arzneimittelforschung; 1988 Dec; 38(12):1792-6. PubMed ID: 2977545
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
Uchida W; Shibasaki K; Asano M
J Cardiovasc Pharmacol; 1992 Jan; 19(1):60-8. PubMed ID: 1375689
[TBL] [Abstract][Full Text] [Related]
31. Effects of nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerin, nifedipine, and propranolol.
Kobayashi K; Hakuta T
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S109-15. PubMed ID: 2447417
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
[TBL] [Abstract][Full Text] [Related]
33. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
34. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
Motomura S; Hashimoto K; Hashimoto K
J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
[TBL] [Abstract][Full Text] [Related]
35. Effects of niguldipine, a new dihydropyridine calcium antagonist, on regional blood flow, cardiac performance and myocardial metabolism in anaesthetized open-chest dogs.
Fischer G; Schneider W; Krumpl G; Grohs JG; Raberger G
Arch Int Pharmacodyn Ther; 1989; 298():96-107. PubMed ID: 2757470
[TBL] [Abstract][Full Text] [Related]
36. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of YM-16151-1 and its optical isomers: a novel calcium entry blocking and beta 1-adrenoceptor blocking agent.
Uchida W; Shibasaki K; Asano M; Takenaka T
Arch Int Pharmacodyn Ther; 1993; 321():30-40. PubMed ID: 8100704
[TBL] [Abstract][Full Text] [Related]
38. Vasodilator action of KB-944, a new calcium antagonist.
Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
[TBL] [Abstract][Full Text] [Related]
39. Influence of dihydropyridine-type calcium agonists on hemodynamics and myocardial ischemia in isolated rabbit hearts.
Rump AF; Rösen R; Sigmund B; Fuchs J; Ratke R; Klaus W
Arzneimittelforschung; 1993 Oct; 43(10):1056-9. PubMed ID: 7505584
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
